Several models have been designed to predict survival of patients with heart failure. These, while available and widely used for both stratifying and deciding upon different treatment options on the individual level, have several limitations. Specifically, some clinical variables that may influence prognosis may have an influence that change over time. Statistical models that include such characteristic may help in evaluating prognosis. The aim of the present study was to analyze and quantify the impact of modeling heart failure survival allowing for covariates with time-varying effects known to be independent predictors of overall mortality in this clinical setting.Survival data from an inception cohort of five hundred patients diagnosed w...
Introduction From a prospective multicentre multicountry clinical trial, we developed and validated ...
Background: Prognostic models developed in general cohorts with a mixture of heart failure (HF) phen...
INTRODUCTION: From a prospective multicentre multicountry clinical trial, we developed and validated...
Background: Several models have been designed to predict survival of patients with heart failure. Th...
BACKGROUND: Several models have been designed to predict survival of patients with heart failure. Th...
AIMS: We aimed to develop prognostic models for patients with chronic heart failure (CHF). METHODS A...
This study was focused on survival analysis of heart failure patients who were admitted to Institute...
Refer to the page 659-667 Heart failure (HF) is a common clinical syndrome with high mor-bidity and ...
The present paper systematically reviews and compares existing prediction models in order to establi...
DOI: 10.5935/abc.20140050 Background: The treatment of heart failure has evolved in recent decades s...
Background: We sought to identify prognostic factors of long-term mortality, specific for the underl...
Objectives: This study sought to review the literature for risk prediction models in patients wit...
Objective: To develop a comprehensive and easily applicable prognostic model predicting mortality ri...
Objective: To develop a comprehensive and easily applicable prognostic model predicting mortality ri...
The existing heart failure risk prediction models are developed based on machine learning predictors...
Introduction From a prospective multicentre multicountry clinical trial, we developed and validated ...
Background: Prognostic models developed in general cohorts with a mixture of heart failure (HF) phen...
INTRODUCTION: From a prospective multicentre multicountry clinical trial, we developed and validated...
Background: Several models have been designed to predict survival of patients with heart failure. Th...
BACKGROUND: Several models have been designed to predict survival of patients with heart failure. Th...
AIMS: We aimed to develop prognostic models for patients with chronic heart failure (CHF). METHODS A...
This study was focused on survival analysis of heart failure patients who were admitted to Institute...
Refer to the page 659-667 Heart failure (HF) is a common clinical syndrome with high mor-bidity and ...
The present paper systematically reviews and compares existing prediction models in order to establi...
DOI: 10.5935/abc.20140050 Background: The treatment of heart failure has evolved in recent decades s...
Background: We sought to identify prognostic factors of long-term mortality, specific for the underl...
Objectives: This study sought to review the literature for risk prediction models in patients wit...
Objective: To develop a comprehensive and easily applicable prognostic model predicting mortality ri...
Objective: To develop a comprehensive and easily applicable prognostic model predicting mortality ri...
The existing heart failure risk prediction models are developed based on machine learning predictors...
Introduction From a prospective multicentre multicountry clinical trial, we developed and validated ...
Background: Prognostic models developed in general cohorts with a mixture of heart failure (HF) phen...
INTRODUCTION: From a prospective multicentre multicountry clinical trial, we developed and validated...